SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or “smile line” wrinkles, today announced its flagship product, ArteFill has been selected as a finalist in the 2007 CONNECT Most Innovative New Products “MIP” Awards.
